Hypoxia-mediated regulation of macrophage functions in pathophysiology

International Immunology

Volumn 25, Issue 2, 2013, Pages 67-75

  Riboldi, Elena ^a   Porta, Chiara ^a   Morlacchi, Sara ^b   Viola, Antonella ^b   Mantovani, Alberto ^b,c   Sica, Antonio ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

B; HIF; NF ; Tumor

Indexed keywords

AMPHOTERICIN B; ANGIOPOIETIN RECEPTOR; BORTEZOMIB; CHEMOKINE RECEPTOR CXCR4; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACINOSTAT; DIGOXIN; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IBUPROFEN; IMATINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1; TANESPIMYCIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOPOTECAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOACCUMULATION; BLOOD OXYGEN TENSION; BONE MARROW CELL; CARTILAGE DEGENERATION; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CONGESTIVE CARDIOMYOPATHY; DOWN REGULATION; EMBRYONIC STEM CELL; ENERGY METABOLISM; FATTY LIVER; GLYCOLYSIS; HEART INFARCTION; HUMAN; HYDROXYLATION; INHIBITION KINETICS; MACROPHAGE; MACROPHAGE FUNCTION; METASTASIS; NONHUMAN; OXYGEN TENSION; PATHOPHYSIOLOGY; PHAGOCYTOSIS; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN TARGETING; PULMONARY HYPERTENSION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; UPREGULATION;

ANOXIA; HUMANS; MACROPHAGES;

EID: 84873879390     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxs110     Document Type: Article

References (103)

1. Semenza, G. L. 2012. Hypoxia-inducible factors in physiology and medicine Cell 148:399.
2. Gordon, S. and Martinez, F. O. 2010. Alternative activation of macrophages: mechanism and functions. Immunity 32:593.
3. Sica, A. and Mantovani, A. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122:787.
4. Sica, A., Melillo, G. and Varesio, L. 2011. Hypoxia: a doubleedged sword of immunity. J. Mol. Med. 89:657.
5. Shapiro, H., Lutaty, A. and Ariel, A. 2011. Macrophages, metainflammation, and immuno-metabolism. Scientific World Journal. 11:2509.
6. Mantovani, A. and Sica, A. 2010. Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22:231.
7. Bingle, L., Brown, N. J. and Lewis, C. E. 2002. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196:254.
8. Taylor, C. T. and Cummins, E. P. 2009. The role of NF-kappaB in hypoxia-induced gene expression. Ann. N. Y. Acad. Sci. 1177:178.
9. Rahat, M. A., Bitterman, H. and Lahat, N. 2011. Molecular mechanisms regulating macrophage response to hypoxia. Front. Immunol. 2:45.
10. Semenza, G. L. 2012. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 33:207.
11. Rius, J., Guma, M., Schachtrup, C. et al. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453:807.
12. Simon, M. C. 2006. Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization. Adv. Exp. Med. Biol. 588:165.
13. Blouin, C. C., Pagé E. L., Soucy, G. M. and Richard, D. E. 2004. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1α. Blood 103:11240.
14. Semenza, G. L. 2010. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625.
15. Rankin, E. B. and Giaccia, A. J. 2008. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15:678.
16. Fang, H. Y., Hughes, R., Murdoch, C. et al. 2009. Hypoxiainducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114:844.
17. Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S. and Nizet, V. 2007. Cutting edge: Essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178:75169.
18. Peyssonnaux, C., Datta, V., Cramer, T. et al. 2005. HIF-1α expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115:18065.
19. Cramer, T., Yamanishi, Y., Clausen, B. E. et al. 2003. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112:645.
20. Leek, R. D., Talks, K. L., Pezzella, F. et al. 2002. Relation of hypoxia-inducible factor-2 α (HIF-2 α) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res. 62:1326.
21. Eubank, T. D., Roda, J. M., Liu, H., O'Neil, T. and Marsh, C. B. 2011. Opposing roles for HIF-1α and HIF-2α in the regulation of angiogenesis by mononuclear phagocytes. Blood 117:323.
22. Chandel, N. S., Trzyna, W. C., McClintock, D. S. and Schumacker, P. T. 2000. Role of oxidants in NF-kappa B activation and TNFalpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 165:1013.
23. Takeda, K., Ichiki, T., Narabayashi, E. et al. 2009. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression. Arterioscler. Thromb. Vasc. Biol. 29:2132.
24. Bonizzi, G. and Karin, M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280.
25. Cummins, E. P., Berra, E., Comerford, K. M. et al. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NF-κB activity. Proc. Natl. Acad. Sci. U.S.A. 103:18154.
26. Patel, S. A. and Simon, M. C. 2008. Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ. 15:628.
27. Wang, Y., Ma, Y. Y., Song, X. L. et al. 2012. Upregulations of glucocorticoid-induced leucine zipper by hypoxia and glucocorticoid inhibit proinflammatory cytokines under hypoxic conditions in macrophages. J. Immunol. 188:222.
28. Ivanović, Z., Bartolozzi, B., Bernabei, P. A. et al. 2000. Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br. J. Haematol. 108:424.
29. Adelman, D. M., Maltepe, E. and Simon, M. C. 2000. HIF-1 is essential for multilineage hematopoiesis in the embryo. Adv. Exp. Med. Biol. 475:275.
30. Takubo, K., Goda, N., Yamada, W. et al. 2010. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7:391.
31. Ĺesque, J. P., Winkler, I. G., Hendy, J. et al. 2007. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Stem Cells 25:1954.
32. Martin, C., Bridger, G. J. and Rankin, S. M. 2006. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro. Br. J. Haematol. 134:326.
33. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J. et al. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858.
34. Schioppa, T., Uranchimeg, B., Saccani, A. et al. 2003. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198:1391.
35. Shi, C. and Pamer, E. G. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11:762.
36. Wang, Y., Cui, L., Gonsiorek, W. et al. 2009. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J. Inflamm. (Lond). 6:32.
37. Turner, L., Scotton, C., Negus, R. and Balkwill, F. 1999. Hypoxia inhibits macrophage migration. Eur. J. Immunol. 29:2280.
38. Murdoch, C., Muthana, M. and Lewis, C. E. 2005. Hypoxia regulates macrophage functions in inflammation. J. Immunol. 175:6257.
39. Lum, J. J., Bui, T., Gruber, M. et al. 2007. The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 21:1037.
40. Roiniotis, J., Dinh, H., Masendycz, P. et al. 2009. Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J. Immunol. 182:7974.
41. Beck-Schimmer, B., Schimmer, R. C., Madjdpour, C., Bonvini, J. M., Pasch, T. and Ward, P. A. 2001. Hypoxia mediates increased neutrophil and macrophage adhesiveness to alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 25:780.
42. Bosco, M. C., Delfino, S., Ferlito, F. et al. 2009. The hypoxic synovial environment regulates expression of vascular endothelial growth factor and osteopontin in juvenile idiopathic arthritis. J. Rheumatol. 36:1318.
43. Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W. and Varesio, L. 1995. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182:1683.
44. Nizet, V. and Johnson, R. S. 2009. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9:609.
45. Anand, R. J., Gribar, S. C., Li, J. et al. 2007. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1α-dependent manner. J. Leukoc. Biol. 82:1257.
46. Hempel, S. L., Monick, M. M. and Hunninghake, G. W. 1996. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 14:170.
47. Kim, S. Y., Choi, Y. J., Joung, S. M., Lee, B. H., Jung, Y. S. and Lee, J. Y. 2010. Hypoxic stress up-regulates the expression of Toll-like receptor 4 in macrophages via hypoxia-inducible factor. Immunology 129:516.
48. Acosta-Iborra, B., Elorza, A., Olazabal, I. M. et al. 2009. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J. Immunol. 182:3155.
49. Kuhlicke, J., Frick, J. S., Morote-Garcia, J. C., Rosenberger, P. and Eltzschig, H. K. 2007. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE. 2:e1364.
50. Appelhoff, R. J., Tian, Y. M., Raval, R. R. et al. 2004. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279:38458.
51. Aragonés, J., Schneider, M., Van Geyte, K. et al. 2008. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat. Genet. 40:170.
52. Schneider, M., Van Geyte, K., Fraisl, P. et al. 2010. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 138:1143-54.e1.
53. Tambuwala, M. M., Cummins, E. P., Lenihan, C. R. et al. 2010. Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology 139:2093.
54. Minamishima, Y. A., Moslehi, J., Bardeesy, N., Cullen, D., Bronson, R. T. and Kaelin, W. G. Jr. 2008. Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood 111:3236.
55. Takeda, K., Ho, V. C., Takeda, H., Duan, L. J., Nagy, A. and Fong, G. H. 2006. Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol. Cell. Biol. 26:8336.
56. Bishop, T., Gallagher, D., Pascual, A. et al. 2008. Abnormal sympathoadrenal development and systemic hypotension in PHD3-/-mice. Mol. Cell. Biol. 28:3386.
57. Mazzone, M., Dettori, D., Leite de Oliveira, R. et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136:839.
58. Minamishima, Y. A., Moslehi, J., Padera, R. F., Bronson, R. T., Liao, R. and Kaelin, W. G. Jr. 2009. A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol. Cell. Biol. 29:5729.
59. Kiss, J., Mollenhauer, M., Walmsley, S. R. et al. 2012. Loss of the oxygen sensor PHD3 enhances the innate immune response to abdominal sepsis. J. Immunol. 189:1955.
60. Escribese, M. M., Sierra-Filardi, E., Nieto, C. et al. 2012. The prolyl hydroxylase PHD3 identifies proinflammatory macrophages and its expression is regulated by activin A. J. Immunol. 189:1946.
61. Porta, C., Riboldi, E., Totaro, M. G., Strauss, L., Sica, A. and Mantovani, A. 2011. Macrophages in cancer and infectious diseases: the 'good' and the 'bad'. Immunotherapy 3:1185.
62. Via, L. E., Lin, P. L., Ray, S. M. et al. 2008. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect. Immun. 76:2333.
63. Daniel, J., Maamar, H., Deb, C., Sirakova, T. D. and Kolattukudy, P. E. 2011. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancylike phenotype in lipid-loaded macrophages. PLoS Pathog. 7:e1002093.
64. Nickel, D., Busch, M., Mayer, D., Hagemann, B., Knoll, V. and Stenger, S. 2012. Hypoxia triggers the expression of human β defensin 2 and antimicrobial activity against Mycobacterium tuberculosis in human macrophages. J. Immunol. 188:4001.
65. Jiang, G., Li, T., Qiu, Y., Rui, Y., Chen, W. and Lou, Y. 2007. RNA interference for HIF-1alpha inhibits foam cells formation in vitro. Eur. J. Pharmacol. 562:183.
66. Konisti, S., Kiriakidis, S. and Paleolog, E. M. 2012. Hypoxia-a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat. Rev. Rheumatol. 8:153.
67. Vergadi, E., Chang, M. S., Lee, C. et al. 2011. Early macrophage recruitment and alternative activation are critical for the later development of hypoxia-induced pulmonary hypertension. Circulation 123:1986.
68. Sica, A., Porta, C., Riboldi, E. and Locati, M. 2010. Convergent pathways of macrophage polarization: The role of B cells. Eur. J. Immunol. 40:2131.
69. Daley, E., Emson, C., Guignabert, C. et al. 2008. Pulmonary arterial remodeling induced by a Th2 immune response. J. Exp. Med. 205:361.
70. Teng, X., Li, D., Champion, H. C. and Johns, R. A. 2003. FIZZ1/ RELMalpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ. Res. 92:1065.
71. Lambert, J. M., Lopez, E. F. and Lindsey, M. L. 2008. Macrophage roles following myocardial infarction. Int. J. Cardiol. 130:147.
72. Jürgensen, J. S., Rosenberger, C., Wiesener, M. S. et al. 2004. Persistent induction of HIF-1alpha and -2alpha in cardiomyocytes and stromal cells of ischemic myocardium. FASEB J. 18:1415.
73. Weinstein, J. R., Koerner, I. P. and Müller, T. 2010. Microglia in ischemic brain injury. Future Neurol. 5:227.
74. Streit, W. J. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40:133.
75. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C. and Kriz, J. 2007. Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J. Neurosci. 27:2596.
76. Takeda, Y., Costa, S., Delamarre, E. et al. 2011. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479:122.
77. Haschemi, A., Kosma, P., Gille, L. et al. 2012. The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism. Cell Metab. 15:813.
78. Haskó G., Csóka, B., Németh, Z. H., Vizi, E. S. and Pacher, P. 2009. A(2B) adenosine receptors in immunity and inflammation. Trends Immunol. 30:263.
79. Haskó G., Kuhel, D. G., Chen, J. F. et al. 2000. Adenosine inhibits IL-12 and TNF-α production via adenosine A2a receptordependent and independent mechanisms. FASEB J. 14:2065.
80. Németh, Z. H., Lutz, C. S., Csóka, B. et al. 2005. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J. Immunol. 175:8260.
81. Xaus, J., Mirabet, M., Lloberas, J. et al. 1999. IFN-gamma up-regulates the A2B adenosine receptor expression in macrophages: a mechanism of macrophage deactivation. J. Immunol. 162:3607.
82. Xaus, J., Valledor, A. F., Cardó M. et al. 1999. Adenosine inhibits macrophage colony-stimulating factor-dependent proliferation of macrophages through the induction of p27kip-1 expression. J. Immunol. 163:4140.
83. Mor, G. and Abrahams, V. M. 2003. Potential role of macrophages as immunoregulators of pregnancy. Reprod. Biol. Endocrinol. 1:119.
84. Folkman, J. 2002. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29(6 Suppl 16):15.
85. Vaupel, P. and Mayer, A. 2007. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26:225.
86. Sullivan, R. and Graham, C. H. 2007. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26:319.
87. Warburg, O. 1956. On respiratory impairment in cancer cells. Science 124:269.
88. Mazurek, S., Boschek, C. B., Hugo, F. and Eigenbrodt, E. 2005. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin. Cancer Biol. 15:300.
89. Du, R., Lu, K. V., Petritsch, C. et al. 2008. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13:206.
90. Müller, A., Homey, B., Soto, H. et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50.
91. Lewis, C. and Murdoch, C. 2005. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167:627.
92. De Palma, M., Venneri, M. A., Galli, R. et al. 2005. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211.
93. Gabrilovich, D. I., Ostrand-Rosenberg, S. and Bronte, V. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12:253.
94. Welford, A. F., Biziato, D., Coffelt, S. B. et al. 2011. TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice. J. Clin. Invest. 121:1969.
95. Corzo, C. A., Condamine, T., Lu, L. et al. 2010. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207:2439.
96. Albina, J. E., Mahoney, E. J., Daley, J. M., Wesche, D. E., Morris, S. M. Jr and Reichner, J. S. 2005. Macrophage arginase regulation by CCAAT/enhancer-binding protein beta. Shock 23:168.
97. Sica, A. and Bronte, V. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117:1155.
98. Melillo, G. 2007. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev. 26:341.
99. Semenza, G. L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3:721.
100. Muthana, M., Giannoudis, A., Scott, S. D. et al. 2011. Use of macrophages to target therapeutic adenovirus to human prostate tumors. Cancer Res. 71:1805.
101. Mazzieri, R., Pucci, F., Moi, D. et al. 2011. Targeting the ANG2/ TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells. Cancer Cell 19:512.
102. Ben-Baruch, A. 2012. The tumor-promoting flow of cells into, within and out of the tumor site: Regulation by the inflammatory axis of TNFα and chemokines. Cancer Microenviron. 5:151.
103. Sawanobori, Y., Ueha, S., Kurachi, M. et al. 2008. Chemokinemediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. Blood 111:5457.